Five prime therapeutics, inc. (FPRX)
CashFlow / TTM
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Dec'14Sep'14Jun'14Mar'14Dec'13Sep'13Jun'13Mar'13
Operating activities
Net loss

-

-

-

-

-

-

-

-

-

-

-

-

-86,100

-

250,537

245,980

247,643

249,647

-58,307

-41,424

-39,816

-37,424

-32,915

-33,061

-30,469

-28,872

0

0

0

Net loss

-121,933

-137,202

-144,598

-155,773

-155,442

-140,447

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization

5,261

5,300

5,121

5,208

5,180

5,000

4,498

3,844

3,136

2,500

2,240

2,072

1,882

1,742

1,636

1,637

1,653

1,678

1,673

1,603

1,561

1,552

1,560

1,611

1,660

1,694

0

0

0

Impairment of fixed assets

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Loss on disposal of property and equipment

-

-

-

-

-

-38

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Stock-based compensation expense

22,425

22,815

25,970

24,948

26,520

29,468

30,350

29,780

32,106

34,173

36,759

38,006

35,371

32,885

29,249

23,791

17,877

11,467

0

0

0

-

-

-

-

-

-

-

-

Amortization of discounts and premiums on marketable securities

1,530

2,163

2,691

2,860

2,541

1,750

830

-62

-926

-1,621

-2,315

-3,064

-3,776

-4,187

-3,873

-3,329

-2,610

-2,025

0

0

0

-

-

-

-

-

-

-

-

Non-cash operating lease expense

2,419

2,351

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Revaluation of preferred stock warrant liability

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

500

0

0

0

Excess tax benefits from employee equity incentive plans

-

-

-

-

-

-

-

-

-

-

-

-

-

-3,123

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

Deferred income taxes

-

-

-

-

-

-

-

-

-

-

-

-

-

15,071

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

Stock-based compensation expense

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

-

0

0

0

Amortization of premium on marketable securities

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

-

0

0

0

Changes in operating assets and liabilities:
Receivables from collaborative partners

-1,197

-999

-1,351

-109

-906

-8,037

659

-1,121

-1,640

9,174

2,049

433

4,149

-95

641

2,681

1,627

3,644

1,575

541

-154

114

-292

35

260

-101

0

0

0

Income tax receivable

-

-

-

-

-

-

-

-

-

-4,670

-3,193

-1,504

3,855

4,670

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

Prepaid, other current assets and other long-term assets

-6,633

-6,800

1,692

6,315

2,432

10,120

671

941

2,485

-4,235

80

2,406

2,302

2,999

2,320

3,375

3,337

4,782

3,530

1,183

1,327

579

1,518

857

920

981

0

0

0

Accounts payable

-3,640

-72

2,455

1,765

3,321

-265

-394

1,145

1,024

1,903

2,361

667

-213

-1,560

-1,037

-699

116

798

846

539

510

701

-352

423

164

-209

0

0

0

Accrued personnel-related expenses

661

-578

-820

-1,532

-723

227

612

-258

510

-801

271

1,362

-170

1,079

1,651

921

1,180

2,260

1,174

775

903

1,661

1,010

644

600

707

0

0

0

Deferred revenue

-3,835

-5,484

-5,912

-6,043

-10,495

-9,670

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Deferred revenue

-

-

-

-

-

-

-

-

-

-

-

0

-15,306

-

-21,069

-19,242

-16,519

-11,789

24,696

24,705

43,995

45,530

15,163

15,712

-4,547

280

0

0

0

Deferred rent

-

-

-

-

-

802

2,209

3,764

4,540

3,699

2,324

800

-792

-768

-743

-718

-655

-513

-483

-452

-461

-549

-354

-154

46

247

0

0

0

Income tax payable

-

-

-

-

-

-

-

-

-

-

-

-

-

-52,843

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

Other accrued liabilities, and other long-term liabilities

-2,028

-5,699

-15,578

988

-9,438

-3,854

0

0

0

-

-

-

12,638

8,909

5,483

4,601

1,480

4,177

0

0

0

-

-

-

-

-

-

-

-

Operating lease liabilities

-3,674

-2,905

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Other accrued liabilities and other long-term liabilities

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

-

0

0

0

Net cash used in operating activities

-

-

-

-

-

-

-

-

-

-

-

-

-73,572

-

268,758

260,143

265,542

289,098

-25,787

-11,404

10,304

15,265

0

0

0

-

-

-

-

Net cash used in operating activities

-96,262

-113,866

-136,825

-139,841

-144,568

-122,514

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

Investing activities
Purchases of marketable securities

158,684

193,063

275,473

290,306

283,122

377,365

293,942

321,858

358,619

330,363

424,661

397,524

541,788

516,752

733,637

694,944

464,847

458,058

173,034

155,217

184,166

158,674

188,714

174,650

145,154

79,776

0

0

0

Maturities of marketable securities

294,120

321,015

398,992

417,842

402,450

386,200

321,500

312,750

367,000

509,500

522,000

534,000

553,500

466,000

492,000

449,000

316,000

222,250

0

0

0

-

-

-

-

-

-

-

-

Maturities of marketable securities

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

-

0

0

0

Purchases of property and equipment

822

1,776

1,762

2,234

11,474

11,331

12,461

13,093

3,957

4,941

4,467

3,674

3,962

2,961

3,033

2,878

2,813

2,426

1,727

2,074

1,783

1,643

1,604

1,268

810

807

0

0

0

Net cash (used in) provided by investing activities

-

-

-

-

-

-

-

-

-

-

-

-

7,750

-

-244,670

-248,822

-151,660

-238,234

-33,261

-64,736

-88,994

-69,362

0

0

0

-

-

-

-

Net cash provided by investing activities

134,614

126,176

121,757

125,302

107,854

-2,496

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

Financing activities
Proceeds from public offering of common stock, net

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

-

-

-

-

Proceeds from public offering of common stock, net of issuance costs

-

-

-

-

-

107,612

0

0

0

-

-

-

-

-

-

-

-

78,693

97,322

118,792

118,782

58,728

0

0

0

-

-

-

-

Excess tax benefits from employee equity incentive plans

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

Proceeds from exercise of stock options

-

-

-

-

-

-

-

-

-

-

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

Proceeds from issuance of common stock under equity incentive plans

-

1,136

1,938

2,093

2,481

3,963

0

0

0

-

-

-

-

8,323

0

0

0

-

-

-

2,798

2,459

0

0

0

-

-

-

-

Repurchase of shares to satisfy tax withholding obligations

1,206

1,599

1,981

2,032

2,075

2,402

2,180

2,821

3,093

13,909

13,584

22,638

22,265

14,054

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

Net cash used in financing activities

-292

-463

-44

60

405

109,173

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

Net increase (decrease) in cash and cash equivalents and restricted cash

38,060

11,847

-15,112

-14,479

-36,309

-15,837

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Supplemental disclosure
Payments under capital lease obligation

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

9

0

0

0

Net cash provided by (used in) financing activities

-

-

-

-

-

-

-

-

-

-

-

-

-20,005

-

-4,669

7,737

4,647

83,840

82,876

82,177

81,492

61,203

0

0

0

-

-

-

-

Net increase in cash and cash equivalents and restricted cash

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Income taxes paid

-

-

-

-

-

-

-

-

-

-

-

-

-

11,433

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

Property and equipment purchases included in accrued liabilities

-

29

613

749

677

716

7,952

8,654

8,016

9,033

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Supplemental cash flow information
Net increase (decrease) in cash and cash equivalents

-

-

-

-

-

-

-

-

-

-

-

-

-

-

19,419

19,058

118,529

134,704

23,828

6,037

2,802

7,106

-64,520

4,164

-6,178

-3,230

0

0

0